Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase II trial

The aim of this international phase II trial was to determine the efficacy and safety profile of weekly vinorelbine plus trastuzumab as first-line chemotherapy for women with HER 2-overexpressing metastatic breast cancer. Sixty-nine patients with tumours overexpressing HER 2 received vinorelbine: 30...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Chan, A, Martin, M, Untch, M, Gil, M G, Guillem-Porta, V, Wojtukiewicz, M, Kellokumpu-Lehtinen, P, Sommer, H L, Georgoulias, V, Battelli, N, Pawlicki, M, Aubert, D, Bourlard, T, Gasmi, J, Villanova, G, Petruzelka, L
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2006
Soggetti:
Clinical Study
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2360530/
https://ncbi.nlm.nih.gov/pubmed/16969343
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603351
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi